Bilcare doubles Crickhowell trial supply capacity

- Last updated on GMT

Related tags: Pharmacology

Indian CMO Bilcare says need to test new drugs in diverse patient groups drove expansion of its cold chain clinical trial supply packaging and storage facility in Crickhowell, Wales.

The expansion comprises a new 30,000 sqft production unit that doubles capacity at the mid Wales plant, which is at the heart of what the contract manufacturing organisation (CMO) described as a “nascent pharmaceutical cluster​.”

Bilcare managing director Mohan Bhandari explained that: “The need to clinically test drug efficacy and safety in diverse population groups across multiple geographic regions is becoming a crucial necessity.

This necessity has lead Bilcare to expand and open new facilities in US, Europe and Asia. With this expansion of the second centre at Crickhowell, we are now geared to cater to ever challenging requirements of our global customers​.”

Related news

Show more

Related products

show more

Laboratory Solutions for COVID-19 Clinical Trials

Laboratory Solutions for COVID-19 Clinical Trials

Q2 Solutions | 10-Jun-2020 | Clinical Study

As a leading laboratory services organization for trials across the globe, we are proud to partner with clients to support COVID-19 clinical trials. Our...

Parents as Gatekeepers for Children with Cancer

Parents as Gatekeepers for Children with Cancer

PRA Health Sciences | 08-Jun-2020 | Technical / White Paper

The RACE for Children Act will require new drugs intended for adult cancer treatment to also be studied in pediatric cancers when the molecular target...

Related suppliers

Follow us

Products

View more

Webinars